Poole Robin, Kennedy Oliver J, Roderick Paul, Fallowfield Jonathan A, Hayes Peter C, Parkes Julie
Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, South Academic Block, Southampton General Hospital, Southampton, Hampshire SO16 6YD, UK.
Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, EH16 4TJ, UK.
BMJ. 2017 Nov 22;359:j5024. doi: 10.1136/bmj.j5024.
To evaluate the existing evidence for associations between coffee consumption and multiple health outcomes. Umbrella review of the evidence across meta-analyses of observational and interventional studies of coffee consumption and any health outcome. PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and screening of references. Meta-analyses of both observational and interventional studies that examined the associations between coffee consumption and any health outcome in any adult population in all countries and all settings. Studies of genetic polymorphisms for coffee metabolism were excluded. The umbrella review identified 201 meta-analyses of observational research with 67 unique health outcomes and 17 meta-analyses of interventional research with nine unique outcomes. Coffee consumption was more often associated with benefit than harm for a range of health outcomes across exposures including high versus low, any versus none, and one extra cup a day. There was evidence of a non-linear association between consumption and some outcomes, with summary estimates indicating largest relative risk reduction at intakes of three to four cups a day versus none, including all cause mortality (relative risk 0.83 (95% confidence interval 0.79 to 0.88), cardiovascular mortality (0.81, 0.72 to 0.90), and cardiovascular disease (0.85, 0.80 to 0.90). High versus low consumption was associated with an 18% lower risk of incident cancer (0.82, 0.74 to 0.89). Consumption was also associated with a lower risk of several specific cancers and neurological, metabolic, and liver conditions. Harmful associations were largely nullified by adequate adjustment for smoking, except in pregnancy, where high versus low/no consumption was associated with low birth weight (odds ratio 1.31, 95% confidence interval 1.03 to 1.67), preterm birth in the first (1.22, 1.00 to 1.49) and second (1.12, 1.02 to 1.22) trimester, and pregnancy loss (1.46, 1.06 to 1.99). There was also an association between coffee drinking and risk of fracture in women but not in men. Coffee consumption seems generally safe within usual levels of intake, with summary estimates indicating largest risk reduction for various health outcomes at three to four cups a day, and more likely to benefit health than harm. Robust randomised controlled trials are needed to understand whether the observed associations are causal. Importantly, outside of pregnancy, existing evidence suggests that coffee could be tested as an intervention without significant risk of causing harm. Women at increased risk of fracture should possibly be excluded.
评估咖啡消费与多种健康结局之间关联的现有证据。对咖啡消费与任何健康结局的观察性和干预性研究的荟萃分析证据进行伞状综述。检索了PubMed、Embase、CINAHL、Cochrane系统评价数据库,并筛选了参考文献。纳入了对所有国家和所有环境中任何成年人群咖啡消费与任何健康结局之间关联进行研究的观察性和干预性研究的荟萃分析。排除了咖啡代谢基因多态性的研究。伞状综述确定了201项观察性研究的荟萃分析,涉及67种独特的健康结局,以及17项干预性研究的荟萃分析,涉及9种独特的结局。在包括高摄入量与低摄入量、任何摄入量与无摄入量以及每天多喝一杯等不同暴露水平下,咖啡消费对一系列健康结局的益处多于危害。有证据表明咖啡消费与某些结局之间存在非线性关联,汇总估计表明,与不喝咖啡相比,每天摄入三到四杯咖啡时,包括全因死亡率(相对风险0.83(95%置信区间0.79至0.88))、心血管死亡率(0.81,0.72至0.90)和心血管疾病(0.85,0.80至0.90)在内的相对风险降低幅度最大。高摄入量与低摄入量相比,患癌风险降低18%(0.82,0.74至0.89)。咖啡消费还与几种特定癌症以及神经、代谢和肝脏疾病的风险降低有关。除了怀孕情况外,通过对吸烟进行充分调整,有害关联在很大程度上被消除,在怀孕情况下,高摄入量与低摄入量/无摄入量相比,与低出生体重(比值比1.31,95%置信区间1.03至1.67)、孕早期(1.22,1.00至1.49)和孕中期(1.12,1.02至1.22)早产以及流产(1.46,1.06至1.99)有关。咖啡饮用与女性骨折风险之间也存在关联,但与男性无关。在通常摄入量水平内,咖啡消费似乎总体安全,汇总估计表明,每天摄入三到四杯咖啡时,对各种健康结局的风险降低幅度最大,且对健康有益的可能性大于有害。需要进行有力的随机对照试验来了解观察到的关联是否具有因果关系。重要的是,在怀孕之外,现有证据表明,咖啡可作为一种干预措施进行测试,而不会有造成重大危害的风险。骨折风险增加的女性可能应被排除在外。